Researchers have created a microfluidic device that could lead to faster, more sophisticated, and lower cost methods for screening drugs for liver toxicity – before the drugs are moved into human trials.
Researchers have created a microfluidic device that could lead to faster, more sophisticated, and lower cost methods for screening drugs for liver toxicity – before the drugs are moved into human trials.